Offer - Urjas Oil for just ₹ 1 X
Zita(Glenmark) is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Diabetes.
The correct dosage of Zita(Glenmark) depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Zita(Glenmark) also has some side effects, the most common being Running nose, Nasal congestion, Sore throat. Besides the aforementioned side effects, there are other adverse effects of Zita(Glenmark) as well, which are listed below. Normally, these side effects of Zita(Glenmark) are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Zita(Glenmark)'s effect during pregnancy is Unknown and Moderate while nursing. It is important to know if Zita(Glenmark) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Zita(Glenmark) related warnings section.
Zita(Glenmark) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Zita(Glenmark) in conditions like Diabetic Ketoacidosis, Diabetes Type 1, Kidney Disease. Some other conditions that can be affected by Zita(Glenmark) are listed in the contraindications section below.
Additionally, Zita(Glenmark) may also adversely react with other medicines. See below for a complete list.
You should also be aware that Zita(Glenmark) is safe while driving, and is addiction.
Zita(Glenmark) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Zita(Glenmark) safe for pregnant women?
No research has not been done till date on the safety of Zita for pregnant women. So its effects on pregnant women are unknown.
Is the use of Zita(Glenmark) safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Zita. Immediately discontinue Zita if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Zita(Glenmark) on the Kidneys?
There can be some harmful effects on your kidneys after taking Zita. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Zita(Glenmark) on the Liver?
You may experience side effects on your liver after taking Zita. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Zita(Glenmark) on the Heart?
Zita has very mild side effects on the heart.
Zita(Glenmark) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Zita(Glenmark) unless your doctor advises you to do so -
Is this Zita(Glenmark) habit forming or addictive?
Zita(Glenmark) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Zita(Glenmark) as it does not make you drowsy.
Is it safe?
Zita(Glenmark) is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Zita(Glenmark) cannot treat any kind of mental disorder.
Interaction between Food and Zita(Glenmark)
Taking Zita(Glenmark) with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Zita(Glenmark)
Consumption of alcohol and Zita(Glenmark) together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Januvia® (sitagliptin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 274-275
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1143-1144